2019
DOI: 10.17116/stomat20199803135
|View full text |Cite
|
Sign up to set email alerts
|

The feasibility of combined lipofilling methods in the treatment of patients with facial hemiatrophy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 4 publications
0
2
0
1
Order By: Relevance
“…A total of 27 studies were included; 68 studies were excluded for the following reasons: 10 studies were excluded because the fat graft was not supplemented; 23 , 31-39 19 studies were excluded because fat graft retention was not assessed by volumetric or patient satisfaction measurements; 40-59 3 studies were excluded because the study methods or intervention were not evaluable due to insufficient description; 60-62 8 studies were excluded because these were conference abstracts; 63-69 13 studies were excluded because these concerned trial registrations; 70-82 1 study was excluded because the supplementation therapy was not carried out in the face, but in other body parts; 83 in 1 study the injection site was not adipose tissue but product was injected within the muscles of the face (facial muscular plane); 84 12 studies were excluded because they did not describe human subjects or clinical results; 85-95 no translation of 1 study was available (Russian). 96 …”
Section: Resultsmentioning
confidence: 99%
“…A total of 27 studies were included; 68 studies were excluded for the following reasons: 10 studies were excluded because the fat graft was not supplemented; 23 , 31-39 19 studies were excluded because fat graft retention was not assessed by volumetric or patient satisfaction measurements; 40-59 3 studies were excluded because the study methods or intervention were not evaluable due to insufficient description; 60-62 8 studies were excluded because these were conference abstracts; 63-69 13 studies were excluded because these concerned trial registrations; 70-82 1 study was excluded because the supplementation therapy was not carried out in the face, but in other body parts; 83 in 1 study the injection site was not adipose tissue but product was injected within the muscles of the face (facial muscular plane); 84 12 studies were excluded because they did not describe human subjects or clinical results; 85-95 no translation of 1 study was available (Russian). 96 …”
Section: Resultsmentioning
confidence: 99%
“…Autologous fat grafting is considered the filler par excellence because it possesses unique characteristics: biocompatibility, versatility, long-lasting effects, and natural appearance [72]. Since the dawn of its use for soft tissue augmentation by Neuber in 1893, the potential of lipofilling has been recognized, and today it emerges as a key technique in several areas of plastic surgery, such as facelift surgery, breast augmentation, and reconstructive surgery in wound healing [73][74][75][76][77]. Within the area of noninvasive cosmetic procedures comes nanofat grafting, first described in 2013 by Tonnard and colleagues, [44,72], that has gained popularity in cosmetic surgery in recent years [78].…”
Section: Adipose-derived Stem Cells (Ascs) and Nanofat Graftingmentioning
confidence: 99%
“…Yog' to'qimasida ildiz hujayralarining tarkibi 30 000 hujayradan 1 tani tashkil qiladi. Shunday qilib, yog' to'qimasini ildiz hujayralarining muqobil manbai deb hisoblash mumkin, chunki uni yog' to'qimalarining bo'laklaridan va lipoaspiratsiya orqali ko'p miqdorda yig'ish mumkin [11][12][13][14].…”
Section: Asosiy Qismunclassified